Biomarqueurs en cancérologie et onco-hématologie (BECCOH)

Présentation du laboratoire

Les activités de recherche du laboratoire BECCOH portent sur les essais cliniques et le développement de biomarqueurs, pour les patients atteints de cancers cutanés, digestifs ou pulmonaires, ou d'histocytoses. Les équipes du laboratoire visent des transversalités fortes en particulier autour du développement et de la validation de biomarqueurs prédictifs et pronostiques permettant une spécification toujours plus poussée de la prise en charge thérapeutique des patients.Le laboratoire BECCOH dispose d'une plateforme de pathologie histologique et moléculaire pour l'étude des néoplasies, et est adossé à un centre de ressources biologiques (CRB) certifié par AFNOR à la norme NF96-900.

Les 20 dernières publications

Titre Auteurs Date de publication Source
Lung transplantation as a rescue option in childhood critical pulmonary Langerhans cell histiocytosis Zofia Helias-Rodzevicz, Jean François Emile 01/01/2024 Pediatric Pulmonology
Persistent nivolumab-induced urticaria with vibratory and delayed-pressure angioedema Romain Salle, Charbel Skayem, C. Longvert, E. Funck-Brentano 01/01/2024 Journal of Allergy and Clinical Immunology: In Practice
Detection of wildtype Merkel cell polyomavirus genomic sequence and VP1 transcription in a subset of Merkel cell carcinoma Astrid Blom 01/01/2024 Histopathology
Treponema pallidum resistance to azithromycin in France: A nationwide retrospective study from 2010 to 2022 Romain Salle 01/01/2024 Journal of the European Academy of Dermatology and Venereology
European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes) P. Saiag 01/01/2024 Journal of the European Academy of Dermatology and Venereology
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023 P. Saiag 01/11/2023 European Journal of Cancer
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023 P. Saiag 01/11/2023 European Journal of Cancer
Avelumab vs Standard Second-Line Chemotherapy in Patients with Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial Jean François Emile 19/10/2023 JAMA oncology
Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma Astrid Blom, P. Saiag 01/10/2023 Journal of Investigative Dermatology
Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patients Jean Donadieu, Jean François Emile 28/09/2023 Blood
Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients Capucine Baldini 01/09/2023 Cancers
Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy Paul Takam Kamga 01/09/2023 Cancers
A suggested protocol for the endocrine postoperative management of patients undergoing pituitary surgery Marie Laure Raffin Sanson 01/08/2023 Annales d'Endocrinologie
PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte-rich tumours Irena Antonia Ungureanu, Jean Donadieu, Jean François Emile 01/08/2023 Histopathology
Atopic dermatitis: A nationwide study on healthcare pathways and patient satisfaction of disease management in France Charbel Skayem, Romain Salle 01/08/2023 Journal of the European Academy of Dermatology and Venereology
H syndrome mimicking Erdheim Chester disease: new entity and therapeutic perspectives Jean François Emile 01/08/2023 Haematologica
Prevalence, patterns and outcomes of cardiac involvement in Erdheim-Chester disease Jean François Emile 07/07/2023 European Heart Journal
Molecular and clinicopathologic characterization of pediatric histiocytoses Zofia Hélias-Rodzewicz, Nathalie Terrones, Rim Ben Jannet, Mariama Bakari, Jean François Emile 01/07/2023 American Journal of Hematology
OCT2 expression in histiocytoses Irena Antonia Ungureanu, Zofia Hélias-Rodzewicz, Jean Donadieu, Jean François Emile 01/07/2023 Virchows Archiv
A nationwide French cohort study on 3154 patients with atopic dermatitis and psoriasis to assess patients' perception of dermatology residents A. Faugeroux, Romain Salle, Charbel Skayem 01/07/2023 Journal of the European Academy of Dermatology and Venereology

Nombre de publications du laboratoire par domaine scientifique (2016-2021)

Chaque publication du laboratoire peut être rangée dans une ou plusieurs disciplines scientifiques : la figure ci-dessus présente le nombre de publications du laboratoire pour chaque discipline de la classification ASJC (Elsevier)